Subscribe

Prolonged Hypoglycemia | Use of Sulfonylurea and Its Treatment with Octreotide

Purpose:

To manage a patient with profound hypoglycemia associated with sulfonylurea therapy.

Specialty:

Endocrinology, Nutrition & Dermatology
Clinical Laboratory

Objective:

adverse effects, overdose and reversal

ICD-10:

E16.0, Y42.3

Description:

Sulfonylureas are long-acting agents that stimulate release of insulin from the beta-cells of the pancreas. If hypoglycemia occurs, then it tends to be prolonged (may be over 24 hours) and it tends to be resistant to standard glucose replacement strategies.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone